Polycistronic Lentiviral Vector for “Hit and Run” Reprogramming of Adult Skin Fibroblasts to Induced Pluripotent Stem Cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stem Cells

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/stem.39PMID 19415770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette

  2009cited by this paper
• Fibroblast-Derived Induced Pluripotent Stem Cells Show No Common Retroviral Vector Insertions

  2009cited by this paper
• Reprogramming of murine and human somatic cells using a single polycistronic vector

  2009cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• Generation of human induced pluripotent stem cells from dermal fibroblasts

  2008cited by this paper
• Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

  2008cited by this paper
• Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

  2008cited by this paper
• Generation of human-induced pluripotent stem cells

  2008cited by this paper
• Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

  2008cited by this paper
• Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition

  2008cited by this paper
• Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

  2008cited by this paper
• Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors

  2008cited by this paper
• Gene replacement therapy for sickle cell disease and other blood disorders.

  2008cited by this paper
• Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells

  2008cited by this paper
• Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.

  2008cited by this paper
• Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

  2008cited by this paper
• Reprogramming of Neural Progenitor Cells into Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2 Expression

  2008cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• Induction of pluripotent stem cells from fibroblast cultures

  2007cited by this paper
• Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

  2007cited by this paper
• Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI

  2006cited by this paper
• Generation of T-cell receptor retrogenic mice

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Correction of sickle cell disease by homologous recombination in embryonic stem cells.

  2006cited by this paper
• Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells.

  2003cited by this paper
• Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'.

  2001cited by this paper
• Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

  1998cited by this paper
• End joining of genomic DNA and transgene DNA in fertilized mouse eggs.

  1995cited by this paper
• Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus

  1989cited by this paper

• A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications

  2025cites this paper
• Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells

  2024cites this paper
• Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy

  2024cites this paper
• Derivation of elephant induced pluripotent stem cells

  2024cites this paper
• Exploring the reprogramming potential of B cells and comprehending its clinical and therapeutic perspective.

  2023cites this paper
• Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.

  2023cites this paper
• RNA-Based Strategies for Cell Reprogramming toward Pluripotency

  2022cites this paper
• Proteomic approach for creation of the protein marker panels to control the quality of human induced pluripotent stem cells

  2022cites this paper
• Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave

  2022cites this paper
• Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives

  2021cites this paper
• Current standards and pitfalls associated with the transfection of primary fibroblast cells

  2021cites this paper
• Die klinische Translation von hiPS-Zellen in Deutschland

  2020cites this paper
• Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy

  2020cites this paper
• Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders

  2019cites this paper
• Special issue on stem cell and tissue engineering in development, disease, and repair

  2019cites this paper
• Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies

  2019cites this paper
• Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications

  2019cites this paper
• Review

  2018cites this paper
• Generation of induced pluripotent stem cells by a polycistronic lentiviral vector in feeder- and serum- free defined culture.

  2018cites this paper
• Production of lentiviral vector with polycistronic transcripts for reprogramming of mouse fibroblast cells

  2018cites this paper
• Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification.

  2018cites this paper
• Biofabrication of Three-Dimensional Neural Tissue Constructs from Human Induced Pluripotent Stem Cells

  2018cites this paper
• Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine.

  2018cites this paper
• Application of Cord Blood and Cord Blood-Derived Induced Pluripotent Stem Cells for Cartilage Regeneration

  2018cites this paper
• Generation of a model for human prostate development using patient derived induced pluripotent stem cells

  2018cites this paper
• Harnessing a mRNA Platform Against Salmonellae

  2018cites this paper
• BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming

  2018cites this paper
• Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications

  2018cites this paper
• Molecular and Cellular Biology of the Right Heart

  2018cites this paper
• Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier.

  2017cites this paper
• Generation of Integration-Free Induced Neurons Using Graphene Oxide-Polyethylenimine.

  2017cites this paper
• Human neural progenitors derived from integration-free iPSCs for SCI therapy

  2017cites this paper
• The Differentiation Stage of Transplanted Stem Cells Modulates Nerve Regeneration

  2017cites this paper
• Generation and characterization of induced pluripotent stem cells from guinea pig fetal fibroblasts

  2017cites this paper
• Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis

  2017cites this paper
• Clinical potentials of human pluripotent stem cells

  2017cites this paper
• Induced Pluripotent Stem Cell (iPSC)–Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs

  2017cites this paper
• 1 Human-Induced Pluripotent Stem Cells: Derivation

  2017cites this paper
• Induced Pluripotent Stem Cell‐Derived Endothelial Cells Overexpressing Interleukin‐8 Receptors A/B and/or C‐C Chemokine Receptors 2/5 Inhibit Vascular Injury Response

  2017cites this paper
• Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells

  2017cites this paper
• Induced Pluripotent Stem Cells (iPSCs) and Nuclear Reprogramming

  2017cites this paper
• Pluripotent Stem Cells and Skeletal Muscle Differentiation: Challenges and Immediate Applications

  2017cites this paper
• Induced pluripotent stem cells as a new getaway for bone tissue engineering: A systematic review

  2017cites this paper
• Generation and characterization of induced pluripotent stem cells from guinea pig fetal fibroblasts

  2017cites this paper
• Induced pluripotent stem cell models of lysosomal storage disorders

  2017cites this paper
• Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction

  2016cites this paper
• Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia

  2016cites this paper
• Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells

  2016cites this paper
• Induced pluripotent stem (iPS) cells from human fetal stem cells.

  2016cites this paper
• Direct Comparison of DNA versus mRNA on the Efficiency of Induced Pluripotent Stem Cells Generation from Human Primary Fibroblasts

  2016cites this paper
• Induced pluripotent stem cells: methods, disease modeling, and microenvironment for drug discovery and screening

  2016cites this paper
• Cre Recombinase and Other Tyrosine Recombinases.

  2016cites this paper
• Extracellular Matrix-mediated Lung Epithelial Cell Differentiation

  2016cites this paper
• Gr upSM Human Induced Pluripotent Stem Cells and their Derivatives for Disease Modeling and Therapeutic Applications in Alzheimer ’ s Disease

  2016cites this paper
• Co-expression networks in generation of induced pluripotent stem cells

  2016cites this paper
• Induced pluripotent stem cells in a marmoset model for Parkinson's disease

  2016cites this paper
• An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs

  2016cites this paper
• Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage

  2016cites this paper
• Induced Pluripotent Stem Cells in Regenerative Medicine

  2016cites this paper
• Evaluation of the Production Methods of Induced Pluripotent Stem Cells: A Short Review

  2016cites this paper
• Generation and characterization of induced pluripotent stem cells in domestic Asian water buffalo (Bubalus bubalis)

  2016cites this paper
• Guidelines for Preclinical Development

  2016cites this paper
• Genetic Heterogeneity of Induced Pluripotent Stem Cells: Results from 24 Clones Derived from a Single C57BL/6 Mouse

  2015influential citation
• Induced pluripotent stem cell-derived neural stem cell therapies for spinal cord injury

  2015cites this paper
• Direct reprogramming of somatic cells: an update

  2015cites this paper
• Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients

  2015cites this paper
• Myocardial Reprogramming Medicine : The Development , Application , and Challenge of Induced Pluripotent Stem Cells

  2015cites this paper
• Advances in reprogramming to pluripotency.

  2015cites this paper
• Vascular diseases await translation of blood vessels engineered from stem cells

  2015cites this paper
• Derivation of Induced Pluripotent Stem Cells

  2015cites this paper
• Modeling Human Severe Combined Immunodeficiency and Correction by CRISPR/Cas9-Enhanced Gene Targeting.

  2015cites this paper
• Molecular mechanisms of induced pluripotency

  2015cites this paper
• Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges

  2015cites this paper
• Development of a vascularized, induced pluripotent stem cell-derived liver-tissue mimic for therapeutic applications.

  2015cites this paper
• Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road Ahead

  2015cites this paper
• The Hope for iPSC in Lung Stem Cell Therapy and Disease Modeling

  2015cites this paper
• KLF4 N-Terminal Variance Modulates Induced Reprogramming to Pluripotency

  2015cites this paper
• A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.

  2014cites this paper
• Evaluation of the pluripotency of human induced pluripotent stem cells (hiPSCs) reprogrammed with integrative and non-integrative protocols and their differentiation into cardiomyocytes

  2014cites this paper
• Vectorology and Factor Delivery in Induced Pluripotent Stem Cell Reprogramming

  2014cites this paper
• Novel cell surface markers identify routes to iPS cells

  2014cites this paper
• Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.

  2014cites this paper
• Induced neural stem cells: methods of reprogramming and potential therapeutic applications.

  2014cites this paper
• All Roads Lead to Induced Pluripotent Stem Cells: The Technologies of iPSC Generation

  2014cites this paper
• Applications of lentiviral vectors in molecular imaging.

  2014cites this paper
• Reprogramming Pediatric Genetic Disorders: Pearson Syndrome, Ring 14 Syndrome, and Fanconi Anemia

  2014cites this paper
• An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities

  2014cites this paper
• Reversible Mitochondrial DNA Accumulation in Nuclei of Pluripotent Stem Cells

  2014cites this paper
• Footprint‐Free Human Induced Pluripotent Stem Cells From Articular Cartilage With Redifferentiation Capacity: A First Step Toward a Clinical‐Grade Cell Source

  2014cites this paper
• The Potential of Using Induced Pluripotent Stem Cells in Skin Diseases

  2014cites this paper
• Molecular and cellular basis of hematopoietic stem cells maintenance and differentiation

  2014cites this paper
• Modeling of human cardiomyopathy with induced pluripotent stem cells.

  2014cites this paper
• Broad T-Cell Receptor Repertoire in T-Lymphocytes Derived from Human Induced Pluripotent Stem Cells

  2014cites this paper
• Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

  2014cites this paper
• In vivo reprogramming of pancreatic acinar cells to three islet endocrine subtypes

  2014cites this paper
• Recent technological updates and clinical applications of induced pluripotent stem cells

  2014cites this paper
• Advances in Pluripotent and Adult Stem Cells for Eye Research

  2014cites this paper
• A Systemic Evaluation of Cardiac Differentiation from mRNA Reprogrammed Human Induced Pluripotent Stem Cells

  2014cites this paper
• P586Modeling hypertrophic cardiomyopathy with human induced pluripotent stem cells

  2014cites this paper
• CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells

  2014cites this paper